PRMT5 inhibition shows in vitro efficacy against H3K27M-altered diffuse midline glioma, but does not extend survival in vivo

Elizabeth Brown(Meharry Medical College), Gillian Farnie(The Francis Crick Institute)
Scientific Reports
January 3, 2024
Cited by 7


Related Papers